The Oncology Institute, Inc.TOIIWNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank70
3Y CAGR-21.4%
5Y CAGR+55.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-21.4%/yr
Quarterly compound
5Y CAGR
+55.3%/yr
Recent deceleration
Percentile
P70
Within normal range
vs 5Y Ago
9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 8.11% |
| Q2 2025 | 1.46% |
| Q1 2025 | 17.85% |
| Q4 2024 | 1.88% |
| Q3 2024 | 10.29% |
| Q2 2024 | 8.83% |
| Q1 2024 | -16.76% |
| Q4 2023 | -10.01% |
| Q3 2023 | 5.70% |
| Q2 2023 | 7.22% |
| Q1 2023 | -9.79% |
| Q4 2022 | 20.22% |
| Q3 2022 | 16.68% |
| Q2 2022 | -9.58% |
| Q1 2022 | 47.87% |
| Q4 2021 | -27.05% |
| Q3 2021 | 4.89% |
| Q2 2021 | 6.74% |
| Q1 2021 | 1.48% |
| Q4 2020 | 5.01% |
| Q3 2020 | 0.90% |
| Q2 2020 | 36.05% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |